Fu Zhiqiang, Li Guolin, Li Zhihua, Wang Yingxue, Zhao Yue, Zheng Shangyou, Ye Huilin, Luo Yuming, Zhao Xiaohui, Wei Lusheng, Liu Yimin, Lin Qing, Zhou Quanbo, Chen Rufu
Department of Hepato-Pancreato-Billiary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Cell Death Discov. 2017 May 29;3:17004. doi: 10.1038/cddiscovery.2017.4. eCollection 2017.
The long intergenic non-coding RNA, regulator of reprogramming (linc-ROR) is an oncogene and plays a key role in the embryonic stem cell maintenance and is involved in cancer progression. The objective of this study was to analyze linc-ROR expression in pancreatic ductal adenocarcinoma (PDAC) and determine the regulation effects of linc-ROR on proliferation and invasion of cancer cells, as well as properties of cancer stem-like cells (CSLCs). In this study, we found that linc-ROR was up-regulated in PDAC tissues and related to poor prognosis. Linc-ROR knockdown in pancreatic cancer cells inhibited cell growth and arrested in G1 phrase. Suppressed linc-ROR expression also attenuated cancer cell migration, invasion, and epithelial-mesenchymal transition. We observed that linc-ROR expression was increased in CSLCs. Importantly, linc-ROR knockdown impaired the properties and tumorigenesis of pancreatic CSLCs . Mechanistically, we found that linc-ROR functioned as a competing endogenous RNA (ceRNA) to several tumor suppressor microRNAs, particularly some members of let-7 family. We conclude that, as a crucial oncogene, linc-ROR promotes cell proliferation, invasiveness and contributes to stem cell properties of CSLCs in PDAC via acting as a ceRNA to regulate function of microRNAs. The linc-ROR is a potential therapeutic target for PDAC.
长链基因间非编码RNA重编程调节因子(linc-ROR)是一种癌基因,在胚胎干细胞维持中起关键作用,并参与癌症进展。本研究的目的是分析linc-ROR在胰腺导管腺癌(PDAC)中的表达,并确定linc-ROR对癌细胞增殖和侵袭以及癌症干细胞样细胞(CSLCs)特性的调节作用。在本研究中,我们发现linc-ROR在PDAC组织中上调,且与预后不良相关。胰腺癌细胞中linc-ROR的敲低抑制了细胞生长并停滞在G1期。linc-ROR表达的抑制也减弱了癌细胞的迁移、侵袭和上皮-间质转化。我们观察到CSLCs中linc-ROR表达增加。重要的是,linc-ROR的敲低损害了胰腺CSLCs的特性和肿瘤发生。机制上,我们发现linc-ROR作为一种竞争性内源RNA(ceRNA)作用于几种肿瘤抑制性微小RNA,特别是let-7家族的一些成员。我们得出结论,作为一种关键的癌基因,linc-ROR通过作为ceRNA调节微小RNA的功能,促进PDAC中细胞的增殖、侵袭性,并有助于CSLCs的干细胞特性。linc-ROR是PDAC的一个潜在治疗靶点。